We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
(-19%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-20.42%
Top 10 Holdings %
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genius Sports
GENI
|
+$4.35M |
| 2 |
PRTY
Party City Holdco Inc.
PRTY
|
+$2.85M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$2.43M |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$2.34M |
| 5 |
Walt Disney
DIS
|
+$2.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$5.34M |
| 2 |
Microsoft
MSFT
|
+$5.22M |
| 3 |
OPLN
Openlane
OPLN
|
+$4.6M |
| 4 |
Apple
AAPL
|
+$4.51M |
| 5 |
Herc Holdings
HRI
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.45% |
| 2 | Industrials | 15.7% |
| 3 | Technology | 14.88% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
MiMedx Group
MDXG
$633M
| $170K | 0.02% |
+28,092
| New | +$195K |
|
1252
Sprinklr
CXM
$1.61B
| $169K | 0.02% |
+10,666
| New | +$174K |
|
|
LOGC
1253
DELISTED
ContextLogic
LOGC
| $166K | 0.02% |
+1,778
| New | +$236K |
|
1254
Bionano Genomics
BNGO
$13.3M
| $164K | 0.02% |
+92
| New | +$246K |
|
1255
Pulse Biosciences
PLSE
$3.02B
| $164K | 0.02% |
+11,102
| New | +$221K |
|
1256
ARKO Corp
ARKO
$635M
| $162K | 0.02% |
18,507
+7,498
| +68% | +$71.9K |
|
|
AUTL
1257
Autolus Therapeutics
AUTL
$562M
| $162K | 0.02% |
31,209
-12,426
| -28% | -$74.6K |
|
|
CPRX
1258
DELISTED
Catalyst Pharmaceutical
CPRX
| $162K | 0.02% |
+23,928
| New | +$157K |
|
1259
Alphatec Holdings
ATEC
$1.44B
| $161K | 0.02% |
+14,070
| New | +$166K |
|
|
CAN
1260
Canaan Creative
CAN
$159M
| $161K | 0.02% |
+31,278
| New | +$235K |
|
|
SRNE
1261
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $161K | 0.02% |
34,701
-662
| -2% | -$4.11K |
|
1262
Amneal Pharmaceuticals
AMRX
$5.79B
| $160K | 0.02% |
+33,402
| New | +$167K |
|
1263
Century Casinos
CNTY
$34M
| $159K | 0.02% |
+13,046
| New | +$183K |
|
1264
CalciMedica
CALC
$10.9M
| $158K | 0.02% |
+6,157
| New | +$239K |
|
1265
CorMedix
CRMD
$584M
| $157K | 0.02% |
34,553
+21,710
| +169% | +$108K |
|
1266
Sphere 3D
ANY
$16M
| $156K | 0.02% |
+714
| New | +$277K |
|
1267
Barings BDC
BBDC
$965M
| $156K | 0.02% |
+14,112
| New | +$156K |
|
1268
CEMIG Preferred Shares
CIG
$6.01B
| $152K | 0.02% |
+105,385
| New | +$152K |
|
|
KALV
1269
DELISTED
KalVista Pharmaceuticals
KALV
| $152K | 0.02% |
+11,499
| New | +$183K |
|
|
BXRX
1270
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $152K | 0.02% |
+496
| New | +$311K |
|
|
DCPH
1271
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $150K | 0.02% |
15,388
-45,162
| -75% | -$849K |
|
1272
Laureate Education
LAUR
$5.28B
| $149K | 0.02% |
+12,202
| New | +$160K |
|
1273
Advantage Solutions
ADV
$361M
| $147K | 0.02% |
733
-1,135
| -61% | -$233K |
|
1274
Passage Bio
PASG
$14.1M
| $147K | 0.02% |
1,154
+55
| +5% | +$8.98K |
|
|
SCS
1275
DELISTED
Steelcase
SCS
| $147K | 0.02% |
+12,566
| New | +$151K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2021 Portfolio in Review
As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.
GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.
- GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
- GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
- GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
- GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
- GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
- GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
- GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.
Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.